Back to Rankings

MBX

MBX BiosciencesN/A
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
MBX vs peer average
50/100
MBX vs. peer average (N/A vs. B)
Grade spread
A 3 · B 3 · C 1 · D 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

CRSP is the first available peer comparator.

Large-cap gene‑editing peer; useful qualitative comparison for pipeline commercialization and partnership dynamics.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCRSPCRISPR Therapeutics
MBX
MBX Biosciences
CRSP
CRISPR Therapeutics
Grade
N/A
B
Momentum
68
43
Value
-
41
Sentiment
73
89
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Unrated
Constructive

Grade position vs CRSP

MBX / CRSP
Grade Position
In line
MBX vs. peer average (N/A vs. B)
50/100
Momentum
68
MBX
Value
-
-
Sentiment
73
CRSP

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MBX
1
CRSP
CRSP
B
80/100
-
2
EDIT
EDIT
B
80/100
-
3
NTLA
NTLA
D
40/100
-
4
FTRE
Fortrea Holdings Inc Common
A
100/100
-
5
VIR
Vir Biotechnology Inc Common
C
60/100
-
CRSP is the first peer returned for this comparison set.